SINOVAC BIOTECH LTD Accrued Liabilities, Current
SINOVAC BIOTECH LTD (SVA) had Accrued Liabilities, Current of $152.71 million as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-06-05
- 2025-12-31: Accrued Liabilities, Current $152.71M.
- 2024-12-31: Accrued Liabilities, Current $156.59M.
- 2023-12-31: Accrued Liabilities, Current $185.37M; Accrued Liabilities, Current as first filed $250.56M.
- 2022-12-31: Accrued Liabilities, Current $240.09M; Accrued Liabilities, Current as first filed $242.53M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $152.71M 20-F · filed 2026-06-05 | |
| 2024-12-31 | $156.59M 20-F · filed 2026-06-05 | |
| 2023-12-31 | $185.37M 20-F · filed 2026-04-30 | $250.56M 20-F · filed 2024-04-29 |
| 2022-12-31 | $240.09M 20-F · filed 2026-04-30 | $242.53M 20-F · filed 2023-05-01 |
| 2021-12-31 | $496.96M 20-F · filed 2026-04-30 | $508.55M 20-F · filed 2022-04-29 |
| 2020-12-31 | $113.69M 20-F · filed 2022-04-29 | |
| 2019-12-31 | $31.14M 20-F · filed 2021-04-22 | |
| 2018-12-31 | $26.81M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $32.62M 20-F · filed 2019-04-29 | |
| 2016-12-31 | $8.60M 20-F · filed 2018-05-11 | |
| 2015-12-31 | $9.65M 20-F · filed 2017-11-22 | |
| 2014-12-31 | $8.33M 20-F · filed 2016-04-25 | $8.34M 20-F · filed 2015-04-29 |
| 2013-12-31 | $8.67M 20-F · filed 2015-04-29 | |
| 2012-12-31 | $7.51M 20-F · filed 2014-04-16 | $7.51M 20-F/A · filed 2013-05-23 |
| 2011-12-31 | $4.12M 20-F/A · filed 2013-05-23 |